The pharmaceutical company said an early peek at its vaccine data suggests it may be 90% effective at preventing COVID-19.
The biotechnology company's potential Alzheimer's drug received a harsh review from a
The burger chain's
The chemicals company received a buyout offer from investment firm 40 North.
The software company will spend up to
The owner of infrastructure businesses will sell its bulk liquid storage and handling business for just under
The cruise line and other travel-related stocks gained ground following encouraging news on the development of a COVID-19 vaccine.
Slumping gold prices on increased hopes for economic recovery weighed on the gold producer.
© 2020 The Canadian Press. All rights reserved., source